OLD

(redirected from Obstructive Lung Disease)
Also found in: Dictionary, Wikipedia.
Related to Obstructive Lung Disease: emphysema, asthma
Category filter:
AcronymDefinition
OLDOld Version (file name extension)
OLDOnline Dating
OLDObstructive Lung Disease (respiratory disease)
OLDOffice of Legislative Drafting (Australia)
OLDOccupational Lung Disease
OLDObsessive Love Disorder (mental health)
OLDOxford Latin Dictionary
OLDOptical Line Distribution
OLDOriginal Drawing
OLDOne-Line Diagram
OLDOutput Linefeed Disposition
OLDOffice of Logic Design (NASA)
OLDOrchid List Digest
OLDOptical Line Driver
OLDOperating Level Days
OLDOff-Load Device
OLDOperations Limitation Document
OLDOperational Logic Diagram
OLDOn-Line Tests and Diagnostics (US DoD)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Prevalence and global initiative for chronic obstructive lung disease group distribution of chronic obstructive pulmonary disease detected by preoperative pulmonary function test.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary.
Using spirometry to confirm a COPD diagnosis is important, as is the subsequent classification of patients based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 ABCD assessment criteria, wherein patients are classified based on patient-reported symptoms and exacerbations.
The analysis evaluated data from four studies and included a total of 3,104 patients with moderate to very severe COPD, which was defined as Global Initiative for Chronic Obstructive Lung Disease stage 2-4.
A study showed that indacaterol-glycopyrronium (a LAMA/LABA combination) was more effectual than salmeterol-fluticasone (a ICS/LABA combination) in preventing COPD exacerbations in patients who had a long history of exacerbations.[12] Another study compared all the currently available LABAs/LAMAs and found that compared to LAMA or LABA/ICS, LAMA/LABA showed greater efficacy and comparable safety profiles, supporting LAMA/LABA combinations as the first-line treatment options for COPD.[13] Moreover, LAMA/LABA provided larger improvement in trough FEV1 versus ICS/LABA.[14] The 2017 guidelines for the Global Initiative for Chronic Obstructive Lung Disease (GOLD) placed LAMA/LABA earlier than ICS in the stepwise escalation of COPD therapy.[15]
While mentioning a list of diseases caused by use of tobacco in different forms, including shisha, he said that smoking caused over 90pc chronic obstructive lung disease cases whose treatment was very difficult and often patients ended up with respiratory failure.
Linnea Hedman, Ph.D., from Umeå University in Sweden, and colleagues used pooled data from the Obstructive Lung Disease in Northern Sweden (6,519 participants) study and the West Sweden Asthma Study (23,753 participants) to estimate the prevalence of e-cigarette use and to investigate the association of e-cigarette use with smoking habits, demographic factors, and respiratory symptoms.
HIV infection and older age independently raised odds of obstructive lung disease in a comparison of HIV-positive and negative smokers 40 or older.
COPD was diagnosed according to the criteria laid out by the Global Initiative of Chronic Obstructive Lung Disease (GOLD) which is based on clinical symptoms and a post bronchodilator values of FEV1/FVC6) episodes of exacerbations per year.
According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines of 2016, it is a common preventable and treatable disease, which is characterized by an airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response to noxious particles or gases in the airways and in the lungs [1].
For this article, we explored how self-management education and use of action plans (information regarding what to do when exacerbations occur) compared to usual care according to the Global Initiative for Chronic Obstructive Lung Disease guidelines.
Five-year follow-up of participants diagnosed with chronic airflow obstruction in a SA Burden of Obstructive Lung Disease (BOLD) survey
Full browser ?